Our-Strategy
Home » Our Strategy

Our Strategy

Driven by innovative science and our entrepreneurial culture, we are focused on the delivery of life-changing medicines that are fueling growth and contributing value to patients and society.

We are guided by our purpose: Doing now what patients need next and the fundamentals of our strategy are clear – to give patients worldwide access to innovative and affordable healthcare. We aim to do this by altering the healthcare paradigm. Our purpose defines our quest to achieve long-term sustainable growth and deliver stakeholder value. The patient is and will remain at the core of what we do, the reason we come to work every day.
Here are the key strategies which steer us towards our goals.

Strategy

We discover, develop and deliver affordable, innovative medicines that help our patients prevail over diseases. Their well-being and convenience are top priority for us. We are committed to respecting the patient community’s independence and to working in a simple, transparent way.

Axigen’s mission to deliver affordable therapeutics that address unmet patient needs through excellence in science. Breakthroughs in science and technology increasingly allow us to find out precisely what is malfunctioning in the body and develop drugs to counter the problem. Our primary focus is on Women’s health, Infertility, Science- based nutritional products and Acute Care. However, we constantly adapt and track the latest insights, to let science show us the way forward. We use deep science and cutting-edge technology to create disruptive solutions and offer affordable alternatives to some of the world’s expensive medicines.
Nearly 2 billion people, a third of the world’s population, lack access to essential medicines; and where healthcare does exist, it is unaffordable. It is time to shift the debate from high-priced, advanced therapeutics to affordable innovation, from market strategies to medical solutions, from mitigating cost to unlocking value. In doing so, we aim to deliver our medicines to as many people as possible and create better patient outcomes. By leveraging India’s scientific advantage, we are moderating costs and widening patient access through high-quality specialty products for chronic ailments such as diabetes, cancer and autoimmune diseases.
We are committed to maintaining the highest quality standards. Our regulatory and quality systems are robust, best-in-class and of global standards. They have earned us the trust of patients, doctors, caregivers, partners and healthcare ecosystems around the world.

We run our business in a way that is ethical and aims to create long-term value for all stakeholders. We want to create value through developing medical solutions and we aim for as many people to benefit from them as possible. We believe that our success lies in our ability to develop strategies where both industry and society benefit in a sustainable way.

We are committed to constantly strengthening and maintaining an excellent workplace where every person feels valued and respected and can grow to his or her full potential. Our people make our business. They discover, develop and manufacture our products and ensure they reach the patients who need them. We believe that the key to our success lies in our ability to attract, retain and motivate a highly skilled and diverse workforce.

We are committed to constantly strengthening and maintaining an excellent workplace where every person feels valued and respected and can grow to his or her full potential. Our people make our business. They discover, develop and manufacture our products and ensure they reach the patients who need them. We believe that the key to our success lies in our ability to attract, retain and motivate a highly skilled and diverse workforce.

Nearly 2 billion people, a third of the world’s population, lack access to essential medicines; and where healthcare does exist, it is unaffordable. It is time to shift the debate from high-priced, advanced therapeutics to affordable innovation, from market strategies to medical solutions, from mitigating cost to unlocking value. In doing so, we aim to deliver our medicines to as many people as possible and create better patient outcomes. By leveraging India’s scientific advantage, we are moderating costs and widening patient access through high-quality specialty products for chronic ailments such as diabetes, cancer and autoimmune diseases.
Axigen’s mission to deliver affordable therapeutics that address unmet patient needs through excellence in science. Breakthroughs in science and technology increasingly allow us to find out precisely what is malfunctioning in the body and develop drugs to counter the problem. Our primary focus is on Women’s health, Infertility, Science- based nutritional products and Primary Care. However, we constantly adapt and track the latest insights, to let science show us the way forward. We use deep science and cutting-edge technology to create disruptive solutions and offer affordable alternatives to some of the world’s expensive medicines.
We run our business in a way that is ethical and aims to create long-term value for all stakeholders. We want to create value through developing medical solutions and we aim for as many people to benefit from them as possible. We believe that our success lies in our ability to develop strategies where both industry and society benefit in a sustainable way.